Status:
UNKNOWN
Atropine vs Isoprenaline in the Invasive Diagnosis of Arrhythmias
Lead Sponsor:
Medical University of Lodz
Conditions:
Cardiac Arrhythmia
Supraventricular Arrhythmia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
During electrophysiological study (EPS) multiple drugs are used to reveal arrhythmias and/or conductive system disorders. Two most often used agents are atropine and isoprenaline. Due to their distinc...
Detailed Description
Electrophysiological study (EPS) is essential tool for heart rhythm disorders diagnostic. Inducibility of arrhythmia before ablation to confirm the diagnosis and inability to do so after the procedure...
Eligibility Criteria
Inclusion
- Patients with indication for electrophysiological study according to present guidelines of European Society of Cardiology
Exclusion
- Not willing or incapable to give written informed consent.
- Previous diagnosed ventricle tachycardia or fibrillation
- Previous diagnosed atrial fibrillation or flutter
- Glaucoma (contraindication for atropine)
Key Trial Info
Start Date :
November 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06082388
Start Date
November 9 2023
End Date
December 1 2025
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Electrocardiology Medical University of Lodz
Lodz, Poland, 93-216